Celcuity (CELC) Projected to Post Quarterly Earnings on Wednesday

Celcuity (NASDAQ:CELC - Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.72) per share for the quarter.

Celcuity Trading Up 0.3 %

Shares of Celcuity stock traded up $0.03 during midday trading on Friday, reaching $10.50. 689,440 shares of the company's stock traded hands, compared to its average volume of 264,765. The company has a market cap of $389.87 million, a PE ratio of -4.02 and a beta of 0.65. The stock has a 50 day moving average of $11.24 and a 200-day moving average of $13.15. Celcuity has a 12 month low of $8.53 and a 12 month high of $22.19. The company has a debt-to-equity ratio of 0.65, a quick ratio of 10.36 and a current ratio of 10.35.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC increased their price target on shares of Celcuity from $23.00 to $29.00 and gave the stock a "buy" rating in a research note on Thursday, February 6th. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Celcuity currently has an average rating of "Buy" and an average target price of $30.17.

Celcuity Company Profile

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.